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Several linkage studies on anxiety have been carried out in samples ascertained through
probands with panic disorder. The results indicated that using a broad anxiety phenotype
instead of a DSM-IV anxiety disorder diagnosis might enhance the chance of finding a linkage
signal. In the current study, a genome-wide linkage analysis was performed on anxiety measured
with a self-report questionnaire whose scores are highly correlated with DSM-IV anxiety
disorders. The self-report questionnaire was included in five surveys of a longitudinal study of
the Netherlands Twin Register. Genotype and phenotype data were available for 1602 twins and
siblings. To estimate identity by descent , additional genotype data for 564 parents and 22
siblings were used. Linkage analyses were carried out using MERLIN-regress on the average
anxiety scores across time. A linkage signal (logarithm of odds score 3.4, empirical P-value 0.07)
was obtained at chromosome 14 for marker D14S65 at 105 cM (90% confidence interval,
99–115 cM bounded by markers D14S1434 and D14S985). This finding replicates a linkage finding
for a broad anxiety phenotype in a clinically based sample, indicating that the region might
harbor a quantitative trait locus associated with the whole spectrum of general anxiety, that is
from the normal to the clinical range. Moreover, genome-wide linkage and association studies on
emotionality in mice obtained significant results in a syntenic region on mouse chromosome 12.
Two homolog genes lie in this region –Dlk1 (delta-like 1 homolog, Drosophila) and Rtl1
(retrotransposon-like 1). Future association studies of these genes are warranted.
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Introduction
Anxiety disorders are common, often with a chronic
and disabling course, and cause significant mental
health-care problems. In epidemiological samples in
the Netherlands and in the United States, lifetime
prevalence rates between 19 and 28% were reported
for any anxiety disorder.1,2 Genetic epidemiological
studies have shown that the etiology of these
disorders is in part genetic with heritability estimates
varying between 23 and 50%.3–5 Several genome-wide
linkage studies have tried to identify genomic regions
harboring quantitative trait loci (QTLs) that influence
the vulnerability for anxiety disorders. All these
studies6–15 ascertained the pedigrees through pro-
bands with panic disorder, except for one study16 that
included pedigrees with at least one member having
an anxiety disorder or somatoform pain. Panic
disorder is the most frequently analyzed pheno-
type.6–8,13,14 Two studies focused on panic disorder
with comorbid medical conditions, that is renal/
bladder conditions, thyroid irregularities, mitral valve
prolapse and severe headaches.11,15 Simple phobia
and social phobia have each been investigated
once.9,10 Other anxiety phenotypes12,14,16 have been
based on findings from genetic epidemiological
studies indicating a common genetic background for
anxiety disorders,4,17 Thorgeirsson et al.16 considered
anxiety disorder or somatoform pain as indicators of
affection status. Smoller et al.14 and Kaabi et al.12
constructed new phenotypes of anxiety proneness.
An overview of the results7,9,10 from these studies
shows that no genomic region has been unequivo-
cally identified to harbor a QTL involved in anxiety.
Table 1 summarizes the most promising results so far.
One region on chromosome 7 and one region on
chromosome 1 showed linkage in two scans6,8,13,14
with logarithm of odds (LOD) scores from 1.71 to 2.23.
A linkage signal on chromosome 14 was observed for
panic disorder, simple and social phobia in a sample
of 20 families with 153 individuals.8–10 The highest
LOD scores ( > 4) have been reported on chromosome
1315 when analyzing panic disorder with comorbid
medical conditions and on chromosomes 412 and 916
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when analyzing a broad anxiety phenotype. The
results of the latter two studies suggest that using a
broad anxiety phenotype might enhance the chance of
finding a linkage signal.
In the current study, linkage analyses were carried
out on longitudinal self-report measures of anxiety,
that is the State Trait Anxiety Inventory (STAI)–Trait
version.18,19 The sample consisted of 1602 siblings
with phenotype and genotype data. Additional
genotype data, available for 564 parents and 22
siblings, were used to estimate identity by descent
(IBD). The families were selected from a Dutch
population-based twin-family sample. Earlier ana-
lyses have shown that, in a sub-sample, the scores
on the STAI are strongly associated with DSM-IV20
diagnoses of panic disorder and/or agoraphobia,
social phobia and generalized anxiety disorder.21
Consequently, it can be considered a broad anxiety
phenotype.
Materials and methods
Subjects
This study is part of a longitudinal survey study of the
Netherlands Twin Register (NTR) that has assessed
twin families roughly every 2 years since 1991.
Sample selection and response rates are described
in detail in Boomsma et al.22 A sub-sample was
approached to provide DNA. For this linkage study,
genotype and STAI data were available for 539
dizygotic male twins and brothers, 758 dizygotic
female twins and sisters and 108 monozygotic male
and 197 monozygotic female twins. DNA was also
available for 249 fathers and 315 mothers and for 22
siblings for whom anxiety data were missing. In total,
566 families and 2188 genotyped subjects were
included in the linkage analyses.
Instruments
In 1991, 1993, 1997, 2000 and 2002, anxiety was
measured with the STAI-trait version,18,19 which
consists of 20 items that are scored on four-point
scales (Cronbach’s a is 0.92). Examples of items are
‘I worry too much over something that really does not
matter’, ‘I feel nervous and restless’, ‘I feel secure’.
The answer categories were ‘almost never’, ‘some-
times’, ‘often’ and ‘almost always’. As the distribution
of the scores was slightly skewed, the scores were log
transformed according to earlier analyses.23
The association between STAI scores and DSM-IV
mood and anxiety disorders, assessed with the
Composite International Diagnostic Interview,24 was
analyzed in a sub-sample of 1248 family members, 521
men and 727 women. Prevalence rates of lifetime major
depression, panic disorder and/or agoraphobia, gener-
alized anxiety disorder and social phobia were respec-
tively 15, 6.4, 5.8 and 4.5%, with higher prevalence
rates in men than in women. Subjects with these
disorders scored significantly higher on the STAI than
subjects without a mood or anxiety disorder. The
difference was more than one standard deviation.21
Analyses of the data obtained in 1991, 1993 and
1997 showed that STAI scores are related to self-
report neuroticism25,26 and depression scores,27–29
with correlations between 0.60 and 0.75.21 Genetic
analyses of the STAI scores showed a heritability of
around 45% without any evidence that different
genes influence variation in men and women, as
correlations between same-sex and opposite-sex twin
and sibling pairs were the same.23
Genotyping
DNA from the siblings and their parents was extracted
from either whole blood or buccal swaps follow-
ing standard protocols.30,31.Samples were genotyped
by the Marshfield Mammalian Genotyping Service
Table 1 Most promising linkage results for anxiety phenotypes (regions with a significant linkage signal or a suggestive linkage
signal found at least twice)
Location LOD N subjects/
families
Phenotype Sample ascertainment
Chromosome 1, 218–234 cM8,14 2.04 153/20 Panic disorder Probands with panic disorder
2.05a 99/1 Anxiety proneness Probands with panic disorder
Chromosome 4, 157 cM12 > 4 153/20 Broad anxiety phenotype Probands with panic disorder
Chromosome 7, 47–57 cM6,13 1.71 /23 Panic disorder Probands with panic disorder
2.23 253/23 Panic disorder Probands with panic disorder
Chromosome 9, 105 cM16 4.18 /25 Anxiety/panic disorder Probands with panic attacks,
GAD or phobias
Chromosome 13, 96 cM15 4.2 /34 Panic disorder combined with
bladder/kidney problems
Probands with panic disorder
Chromosome 14, 36–45 cM8–10 3.7 129/14 Simple phobia Probands with panic disorder
2.93b 163/17 Social phobia Probands with panic disorder
2.38a 153/20 Panic disorder Probands with panic disorder
Abbreviations: LOD, logarithm of odds; NPL, nonparametric linkage; Zlr, likelihood ratio z-score.
aThis is the NPL score, not the LOD score.
bThis is the Zlr score, not the LOD score.
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and/or the Molecular Epidemiology Section, Leiden
University Medical Centre. The genotype data from
these screens were combined. Allele calling and
binning were equalized between markers that were
present in multiple scans, usingB30 control samples.
In case there were inconsistencies, the data were set
to unknown for tested markers (binning and allele
calling inconsistencies) and persons (genotyping
errors). Sex and prior measured zygosity were
checked with the marker data. Pedigree relations in
the entire samples were checked with the GRR
program.32 Errors of Mendelian inheritance were
detected with Pedstats.26 Markers and samples were
removed if their total error rate was more than 1%; in
all other cases, the specific erroneous genotypes were
set as unknown. Unlikely recombinants were de-
tected using Merlin and erroneous genotypes were
removed with Pedwipe.33
After cleaning, only sib-pairs that had at least 280
autosomal markers genotyped for each individual
were selected. The average number of markers
genotyped in siblings was 366 (range 280–761) and
the average heterozygosity of autosomal markers was
75% with an average spacing of 7 cM. For the
statistical analyses, the Haldane mapping function
was used. The marker positions were interpolated via
locally weighted linear regression from the National
Center for Biotechnology Information (NCBI) build
35.1 physical map positions and the Rutgers genetic
map.34,35 The information of the parents and siblings
without phenotypes was used to obtain estimates of
the IBD status of the sibling pairs (see below).
Statistical analysis
The sib-pair strategy to map loci influencing quanti-
tative traits is based on identifying marker alleles that
are inherited IBD. If a marker is co-segregating with a
trait, then siblings whose trait values are more alike
are more likely to receive the same alleles IBD at a
closely linked marker locus than siblings whose
resemblance for the trait is less. IBD refers to the fact
that siblings share a particular allele because they
received it from the same parent. The number of
alleles that are IBD in sib-pairs is thus 0, 1 or 2, but
unless both parents are heterozygous for different
marker alleles, it is not always possible to determine
IBD status exactly. In families in which the parents
are not genotyped, IBD is estimated using population
allele frequencies for the markers. Allele frequencies
were obtained from the observed genotype data.
Linkage analysis was carried out in MERLIN-
regress.36 The regression analysis implemented in
this software package is based on a modified method
initially proposed by Haseman and Elston to investi-
gate linkage in sibling pairs.37 In brief, the multipoint
IBD sharing is regressed on trait squared sums and
squared differences, among all pairs of siblings.36 The
trait squared sums and differences indicate the
resemblance between the siblings. The method takes
into account incomplete IBD information. Mean,
variance and heritability are user-specified.
Anxiety scores were adjusted for age and sex, as
women score higher and older subjects score some-
what lower. The sex and age-adjusted scores were
averaged over the five measurement occasions. In
MERLIN-regress, repeated measures can be entered in
the analysis as an average across occasions with
further specification of the test–retest correlation and
the number of measurements for each individual (in
this case, varying from 1 to 5) to readjust the trait
variance.38 The intra-class correlation between the
five measures was estimated in SPSS using a mixed
model procedure, which allows using all available
data, even of the subjects who did not participate
every occasion.
The 1-LOD-drop support interval was used as an
estimate for the 90% confidence interval of any QTL
locations,32 and was used to examine linkage replica-
tion compared to previously reported locations and
candidate genes (using Ensembl: www.Ensembl.org
and OMIM: www.ncbi.nlm.nih.gov/entrez/query.
fcgi?db = OMIM).
Empirically derived P-values were calculated from
1000 simulated data sets using the gene-dropping
method implemented in MERLIN-regress.39
Results
Mean age and anxiety scores across the five occasions
were calculated for the total sample (N = 11 336) of
twins and siblings and for the linkage sample
(N = 1606). The subjects who provided DNA were
slightly older than the total sample of twins and
siblings (31.6 versus 27.1 years). The anxiety scores
were comparable (33.6 and 33.5 with standard
deviations of 8.0 and 8.5 respectively). After the log-
transformation, the scores were normally distributed
in both samples.
The heritability was specified at 42%. This estimate
was based on analyses in MERLIN-regress using the
option ‘random sample’ and was comparable to the
results of earlier genetic epidemiological analyses of
STAI scores.23 Subjects had participated on average
three times. The intra-class correlation of the five
anxiety measures was 0.58.
Figure 1 shows the results of the linkage analysis.
An LOD score of 3.4 (empirical P-value = 0.07) was
found on chromosome 14 at 105 cM (90% confidence
interval 99–115 cM). There was no other region with
suggestive or significant linkage. Figure 2 shows the
linkage results for chromosome 14 indicating that
marker D14S65 showed the highest LOD score and
the linkage peak was bounded by markers D14S1434
and D14S985.
Discussion
A genome-wide linkage study on a broad anxiety
phenotype was performed in a sample of 1602 twins
and siblings with additional genotype data of 564
parents and 22 siblings used to estimate the IBD
status of the sibling pairs. There was evidence for
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linkage on chromosome 14 at 105 cM with an LOD
score of 3.4 and an empirical P-value of 0.07.
For the same region at chromosome 14, Kaabi
et al.12 reported a significant linkage result (nominal
P = 0.005 and empirical P = 0.04). However, after
adjusting for sib-pair age differences, the signal
disappeared (nominal P = 0.07, empirical P not given).
Possible explanations for the loss of linkage signal
after age adjustment, as given by the authors, are
chance owing to power loss or differential gene
expression at different ages. The first explanation
seems to be the most probable. First, for the sib-pair
age difference to be a confounding factor in a linkage
analysis, it is necessary that it is associated both with
the amount of resemblance between siblings and with
the IBD status. It seems unlikely that sib-pair age
difference is associated with IBD status.
Second, this region on chromosome 14 is syntenic
with a region showing a significant association with
emotionality in mice measured in two previous
linkage studies (chromosome 12, 41–61 cM)40,41 and
in a recent genome-wide association analysis.42,43
The linkage studies were carried out in inbred
mouse strains whose open field activity (OFA) was
Figure 1 Results of the genome-wide linkage analysis of the anxiety scores averaged across the five occasions.
Figure 2 Results of the genome-wide linkage analysis for chromosome 14 with the position of the markers in cM (Haldane)
on the x axis.
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measured. Genome-wide association was analyzed in
heterogeneous mice stocks. Multiple complex pheno-
types were investigated in the heterogeneous mice
stocks and the results are freely available on http://
gscan.well.ox.ac.uk.42,43 Unconditioned anxiety was
measured with the elevated plus maze (EPM), OFA
and food hyponeophagia (FN). Genome-wide signifi-
cance was found in the region syntenic with our
linkage signal for the open arm latency in the EPM.
Two homolog genes lie in this region, that is Dlk1
(delta-like 1 homolog (Drosophila)) and Rtl1 (retro-
transposon-like 1). The function of these genes is still
unknown, although for Dlk1, it has become clear that
this gene is over expressed in brain tumors.44,45 None
of these genes have ever been related to anxiety, but
the results of the studies in mice together with our
results indicate that it may be worthwhile to inves-
tigate the association. A further search did not reveal
other genes under this peak that have been related to
symptoms of anxiety. This does not exclude that they
play a role, but it seems more obvious to start
investigating Dlk1 or Rtl1.
We have not replicated any other of the previous
promising linkage results as summarized in Table 1.
An explanation for this divergence in results could be
the ascertainment of the sample. In contrast to the
other studies in which the pedigrees are ascertained
through probands with panic disorder or another
anxiety disorder, our sample is selected from a Dutch
population-based twin-family sample. One advantage
of a clinical-based sample is that the chance that the
most extreme subjects from the population, who have
the largest burden of disease, are included in the
analysis is high. A disadvantage, on the other hand, is
that a clinical sample can be biased by, for example,
help-seeking behavior or a high prevalence of a
comorbid disorder. This signifies that a linkage signal
can be not only due to the disease, but also due to
other characteristics of a clinical sample. As our
significant linkage result was also previously found
in a clinical sample,12 the region on chromosome
14 is possibly associated with the whole spectrum
of general anxiety, that is from the normal to the
clinical range.
Another reason that no replication to earlier results
was seen could lie in the definition of phenotype
across different studies. Scores on the STAI are highly
associated with a diagnosis of generalized anxiety
disorder, but less with panic disorder and/or agor-
aphobia and intermediately with social phobia.21
Furthermore, it has been suggested that the STAI
measures not only anxiety, but also depression.46
However, results of linkage studies of major depres-
sion did not overlap with our findings either.46
A review on the comorbidity between anxiety and
depression showed that anxiety and depression might
be influenced by shared genes, possibly expressed in
the personality trait neuroticism.17 Linkage findings
for neuroticism were summarized by Fullerton et al.47
and do not include findings on chromosome 14 in
humans.
To summarize, the current linkage study suggests
that the region on chromosome 14, around 105 cM,
could harbor a gene associated with anxiety. The
region is also syntenic with regions found to be
associated with emotionality in mice40,41 (http://
gscan.well.ox.ac.uk). Further association studies
could focus on the homolog genes Dlk1 and Rtl1.
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